Cargando…

Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging

Detalles Bibliográficos
Autores principales: Ladang, Aurélie, Beaudart, Charlotte, Reginster, Jean-Yves, Al-Daghri, Nasser, Bruyère, Olivier, Burlet, Nansa, Cesari, Matteo, Cherubini, Antonio, da Silva, Mario Coelho, Cooper, Cyrus, Cruz-Jentoft, Alfonso J., Landi, Francesco, Laslop, Andrea, Maggi, Stefania, Mobasheri, Ali, Ormarsdottir, Sif, Radermecker, Régis, Visser, Marjolein, Yerro, Maria Concepcion Prieto, Rizzoli, René, Cavalier, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449976/
https://www.ncbi.nlm.nih.gov/pubmed/37488204
http://dx.doi.org/10.1007/s00223-023-01114-y
_version_ 1785095087490859008
author Ladang, Aurélie
Beaudart, Charlotte
Reginster, Jean-Yves
Al-Daghri, Nasser
Bruyère, Olivier
Burlet, Nansa
Cesari, Matteo
Cherubini, Antonio
da Silva, Mario Coelho
Cooper, Cyrus
Cruz-Jentoft, Alfonso J.
Landi, Francesco
Laslop, Andrea
Maggi, Stefania
Mobasheri, Ali
Ormarsdottir, Sif
Radermecker, Régis
Visser, Marjolein
Yerro, Maria Concepcion Prieto
Rizzoli, René
Cavalier, Etienne
author_facet Ladang, Aurélie
Beaudart, Charlotte
Reginster, Jean-Yves
Al-Daghri, Nasser
Bruyère, Olivier
Burlet, Nansa
Cesari, Matteo
Cherubini, Antonio
da Silva, Mario Coelho
Cooper, Cyrus
Cruz-Jentoft, Alfonso J.
Landi, Francesco
Laslop, Andrea
Maggi, Stefania
Mobasheri, Ali
Ormarsdottir, Sif
Radermecker, Régis
Visser, Marjolein
Yerro, Maria Concepcion Prieto
Rizzoli, René
Cavalier, Etienne
author_sort Ladang, Aurélie
collection PubMed
description
format Online
Article
Text
id pubmed-10449976
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-104499762023-08-26 Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging Ladang, Aurélie Beaudart, Charlotte Reginster, Jean-Yves Al-Daghri, Nasser Bruyère, Olivier Burlet, Nansa Cesari, Matteo Cherubini, Antonio da Silva, Mario Coelho Cooper, Cyrus Cruz-Jentoft, Alfonso J. Landi, Francesco Laslop, Andrea Maggi, Stefania Mobasheri, Ali Ormarsdottir, Sif Radermecker, Régis Visser, Marjolein Yerro, Maria Concepcion Prieto Rizzoli, René Cavalier, Etienne Calcif Tissue Int Correction Springer US 2023-07-24 2023 /pmc/articles/PMC10449976/ /pubmed/37488204 http://dx.doi.org/10.1007/s00223-023-01114-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Ladang, Aurélie
Beaudart, Charlotte
Reginster, Jean-Yves
Al-Daghri, Nasser
Bruyère, Olivier
Burlet, Nansa
Cesari, Matteo
Cherubini, Antonio
da Silva, Mario Coelho
Cooper, Cyrus
Cruz-Jentoft, Alfonso J.
Landi, Francesco
Laslop, Andrea
Maggi, Stefania
Mobasheri, Ali
Ormarsdottir, Sif
Radermecker, Régis
Visser, Marjolein
Yerro, Maria Concepcion Prieto
Rizzoli, René
Cavalier, Etienne
Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
title Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
title_full Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
title_fullStr Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
title_full_unstemmed Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
title_short Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
title_sort correction: biochemical markers of musculoskeletal health and aging to be assessed in clinical trials of drugs aiming at the treatment of sarcopenia: consensus paper from an expert group meeting organized by the european society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (esceo) and the centre académique de recherche et d'expérimentation en santé (cares sprl), under the auspices of the world health organization collaborating center for the epidemiology of musculoskeletal conditions and aging
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449976/
https://www.ncbi.nlm.nih.gov/pubmed/37488204
http://dx.doi.org/10.1007/s00223-023-01114-y
work_keys_str_mv AT ladangaurelie correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT beaudartcharlotte correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT reginsterjeanyves correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT aldaghrinasser correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT bruyereolivier correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT burletnansa correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT cesarimatteo correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT cherubiniantonio correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT dasilvamariocoelho correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT coopercyrus correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT cruzjentoftalfonsoj correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT landifrancesco correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT laslopandrea correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT maggistefania correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT mobasheriali correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT ormarsdottirsif correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT radermeckerregis correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT vissermarjolein correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT yerromariaconcepcionprieto correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT rizzolirene correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu
AT cavalieretienne correctionbiochemicalmarkersofmusculoskeletalhealthandagingtobeassessedinclinicaltrialsofdrugsaimingatthetreatmentofsarcopeniaconsensuspaperfromanexpertgroupmeetingorganizedbytheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmu